FDA Approves Tirzepatide as First Drug for Obstructive Sleep Apnea
Samantha Anderer
Abstract
The US Food and Drug Administration (FDA) recently approved tirzepatide, marketed as Zepbound, for moderate to severe obstructive sleep apnea (OSA) in adults with obesity, making it the first sleep apnea drug, according to an agency press release.
Topics & Concepts
MedicineObstructive sleep apneaDrugSleep apneaIntensive care medicineAnesthesiaPharmacologyObstructive Sleep Apnea Research